| 1 | 1282588 | Neurohormonal and blood pressure responses to low-dose infusion of an orally active renin inhibitor, Ro 42-5892, in salt-replete men. | J Cardiovasc Pharmacol | 1992 Dec |
1 |
| 2 | 1502199 | Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. | Proc Natl Acad Sci U S A | 1992 Aug 15 |
2 |
| 3 | 1720828 | Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans. | J Cardiovasc Pharmacol | 1991 Sep |
1 |
| 4 | 1728438 | Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. | Circulation | 1992 Jan |
1 |
| 5 | 1830563 | Ro 42-5892 is a potent orally active renin inhibitor in primates. | Hypertension | 1991 Jul |
4 |
| 6 | 1873015 | Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact. | Am J Hypertens | 1991 Jul |
1 |
| 7 | 1889841 | Renin release regulation during acute renin inhibition in normal volunteers. | Hypertension | 1991 Sep |
1 |
| 8 | 2203486 | Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension. | BMJ | 1990 Jul 28 |
1 |
| 9 | 7586899 | Clinical pharmacokinetics and efficacy of renin inhibitors. | Clin Pharmacokinet | 1995 Jul |
1 |
| 10 | 7678159 | Renin inhibitors as an example of presumptive irrelevant positive findings in the Salmonella/mammalian microsome assay (Ames test). | Mutat Res | 1993 Feb |
1 |
| 11 | 7769797 | Responses to an orally active renin inhibitor, remikiren (Ro 42-5892), after controlled salt depletion in humans. | J Cardiovasc Pharmacol | 1995 Mar |
2 |
| 12 | 7795817 | Determination of the renin inhibitor Ro 42-5892 in human plasma by automated pre-column derivatization, reversed-phase high-performance liquid chromatographic separation and electrochemical detection after post-column irradiation. | J Chromatogr B Biomed Appl | 1995 Mar 24 |
2 |
| 13 | 8206619 | Vascular renin in the guinea pig. Suppression by the renin inhibitor remikiren. | Hypertension | 1994 Jun |
1 |
| 14 | 8207739 | Time dependency of the antihypertensive efficacy of the new renin inhibitor Ro 42-5892. | J Hum Hypertens | 1994 Feb |
2 |
| 15 | 8222499 | Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension. | Clin Pharmacol Ther | 1993 Nov |
1 |
| 16 | 8228207 | Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. | J Hypertens | 1993 Aug |
4 |
| 17 | 8512659 | Effects of an orally active renin inhibitor, Ro 42-5892, in patients with essential hypertension. | Am J Hypertens | 1993 May |
2 |
| 18 | 8613199 | Human renin-dependent hypertension in rats transgenic for human angiotensinogen. | Hypertension | 1996 Mar |
3 |
| 19 | 8674188 | Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. | Clin Chem | 1996 Jul |
1 |
| 20 | 8730920 | Excretion and metabolism of remikiren, a potent orally active inhibitor of primate renin. | Xenobiotica | 1996 Mar |
1 |
| 21 | 8730924 | Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates. | Xenobiotica | 1996 Mar |
1 |
| 22 | 8783774 | Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone system. | Am J Hypertens | 1996 Jun |
2 |
| 23 | 9095095 | Dose effects of human renin in rats transgenic for human angiotensinogen. | Hypertension | 1997 Apr |
2 |
| 24 | 9858773 | Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation. | Biochim Biophys Acta | 1998 Nov 10 |
2 |
| 25 | 12959271 | Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patients. | Br J Clin Pharmacol | 1993 Dec |
2 |
| 26 | 26421414 | Elucidation of the binding mechanism of renin using a wide array of computational techniques and biological assays. | J Mol Graph Model | 2015 Nov |
1 |
| 27 | 30039962 | Electrocatalytic Reduction of Nitrate Using Magnéli Phase TiO<sub>2</sub> Reactive Electrochemical Membranes Doped with Pd-Based Catalysts. | Environ Sci Technol | 2018 Aug 21 |
3 |
| 28 | 34514971 | Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study. | J Biomol Struct Dyn | 2021 Sep 13 |
4 |